Clinical Trial Update: Omega-3 Fatty Acid Administration in Dialysis Patients [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating omega-3 fatty acid administration in dialysis patients with end-stage renal disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Vanderbilt University | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED